All News

Pooled analysis of 16 observational RA registries (27 583 patients) shows that seropositivity was associated with better remission, LDAS and withdrawal rates for RTX and ABA, but not TNF inhibitors. https://t.co/aNphJpB7JB

Links:

Dr. John Cush RheumNow ( View Tweet)

Mar 01, 2021
QD Clinic - RA or Not? Lessons from the clinic. Enough serology, but not enough joints - when does it become RA? https://t.co/akklOklPee

Links:

Dr. John Cush RheumNow ( View Tweet)

Feb 28, 2021
We are three weeks out from RheumNow Live. Are you planning on attending? https://t.co/vJlU0Z3Q3x

Links:

Dr. John Cush RheumNow ( View Tweet)

Feb 26, 2021
News Feature: Measurable Benefits withTreat-to-Target Management in RA https://t.co/iAvLWJGTXp https://t.co/XNtGhoWs5I

Links:

Dr. John Cush RheumNow ( View Tweet)
Feb 26, 2021
We are excited to share that Roy Fleischmann will be leading a discussion on future therapy in RA at RheumnNow Live next month. Sign up today to attend in person or virtually. https://t.co/vJlU0Z3Q3x https://t.co/uN1MrzWZA9

Links:

Dr. John Cush RheumNow ( View Tweet)
Feb 25, 2021
T2T.RA_.jpg

Measureable Benefits to Treat-to-Target Management in RA

Jack Cush, MD
Feb 24, 2021

Desai and colleagues have published that when a learning collaborative group focused on a treat‐to‐target approach was compared to usual care, a modest but significant impact on implementation, treatment changes and patient outcomes in RA patients managed with a treat‐to‐target approach was seen.

Read Article
Cohort analysis of 12351 RA patients from CPRD registry - finds RA on both glucorticoids & PPI have a greater risk OP fractures (adj HR: 1.60, 95% CI: 1.35 to 1.89) vs non-use. Higher than the Fx Risk with either oral GC or PPI use alone (adj HR 1.2). https://t.co/oPMnJoHCjX https://t.co/eW7rpVeHa4

Links:

Dr. John Cush RheumNow ( View Tweet)
Feb 24, 2021
Retrospective cohort study shows the risk of RA was lower in T2DM/diabetes (aHR 0.73; 95% CI 0.67–0.79) vs without T2DM. This risk was lost in when statins were not used (aHR 0.89; 0.69–1.14). Statins (in T2DM) had a protective effect against RA onset https://t.co/CfMJIuGOXI

Links:

Dr. John Cush RheumNow ( View Tweet)

Feb 24, 2021
We are excited to announce that Jeff Sparks ( @jeffsparks) will be leading a discussion on ILD in RA at RheumNow Live this March. Register to attend today. https://t.co/uwxOVh142F https://t.co/bnittqkhKQ

Links:

Dr. John Cush RheumNow ( View Tweet)
Feb 23, 2021
QD Clinics- The Sawtooth Steroid Taper Sawtooth Steroid Taper Surgery Rules for DMARDs & Biologics RA & DVT Traveling to Medical Meetings during COVID Hemoptysis and SLE When to do Genetic Testing in Febrile Patients https://t.co/dZLqGUyizG https://t.co/PYsH7K6ByB

Links:

Dr. John Cush RheumNow ( View Tweet)
Feb 23, 2021
Analysis of incident #RA in UK Clinical Practice registry shows recent prednisone >=7.5mg/d is assoc w/ hypertension in RA. In 17760 RA pts, 42% were Rx steroids; recent GC yielded a 17% increase in HTN (HR 1.17); only >7.5mg/D implicated https://t.co/qUKs2oZZUV https://t.co/pWmD4nKs6U

Links:

Dr. John Cush RheumNow ( View Tweet)
Feb 22, 2021
QD Clinic - RA and DVT Counseling Patients on JAKs and Thrombotic Risk https://t.co/efQGtkrxHF https://t.co/mfhjZYMlUC

Links:

Dr. John Cush RheumNow ( View Tweet)
Feb 18, 2021
RWCS Highlights - Day 4 from Dr. Rachel Tate ( @uptotate) -Novel Therapies Year in Review (RA, SLE, OA) -Novel concepts in Pediatric Rheumatology -TeleRheumatology Update: Post-COVID, Pre-?? https://t.co/JoTV25suxD https://t.co/Id19zgRT37

Links:

Dr. John Cush RheumNow ( View Tweet)
Feb 17, 2021
30 #RA pts treated w/ tofacitinib x 12 mos w/ signif improvement in DAS28, CRP, & HAQ and attenuation of further bone loss, as measured by significantly increased osteocalcin, OPG, and vitamin D3, with decreased CTX levels correlating w/ DXA results https://t.co/RSXL38cJvs

Links:

Dr. John Cush RheumNow ( View Tweet)

Feb 16, 2021
🔥 Increased baseline prevalence and 40% higher risk of developing #Multimorbidity after #RA incidence/index vs general population @CrowsonCindy @JohnDavisIII #MayoClinicRheumatology ⁦@jrheum⁩ ⁦@NIAMSFunding⁩ ⁦@NIH⁩ https://t.co/8GolTowAGm

Links:

Elena MyasoedovaMD MyasoedovaElena ( View Tweet)

Feb 16, 2021
rwcsmtg.jpeg

RWCS Highlights - Day 3

Rachel Tate, DO
Feb 15, 2021

Day 3 report from the 2021 RWCS meeting in Maui (and virtually) includes pearls from the PsA 2020 Year in Review; fact vs. fiction on evidence based medicine: diet and rheumatic diseases; hot topics in allergy/immunology; and pediatric rheumatology highlights.

Read Article
Prospective study of 162 early RA pts looked at Xrays (baseline & 5 yrs). RF & ESR predicted erosion & JSN progression; CCP predicted erosions; Smoking & high DAS28 > 5.1 predicted progression of erosions. Obesity negatively predicted JSN progression https://t.co/fue121hHVw

Links:

Dr. John Cush RheumNow ( View Tweet)

Feb 15, 2021
Dr. Troum considers curcumin 500mg with black pepper BID for patients with inflammatory arthritis. Unclear if there is a relationship or need for monitoring for those with concomitant NSAIDs. #RWCS2021 #RWCS @RWCSmtg @RheumNow https://t.co/9sSWwWTtyv
Dr. Rachel Tate uptoTate ( View Tweet)
Feb 13, 2021
1975: Nixon & Bresnev, in effort of medical diplomacy, cooperated on JRA trials. (Fact: Stalin's personal physician was a rheumatologist.) Dr. Steven's shares an interesting historical slide about this collaboration. #RWCS2021 #RWCS @RWCSmtg @RheumNow https://t.co/Px71qfqDcy
Dr. Rachel Tate uptoTate ( View Tweet)
Feb 13, 2021
obese.waist__0.jpg

Weekly Semaglutide for Weight Loss in Adults

Jack Cush, MD
Feb 11, 2021

NEJM has reported the results of a trial showing semaglutide once weekly plus lifestyle intervention was associated with sustained, weight loss in overweight or obese adults; such that nearly one-third lost over 20% of their body weight.

Read Article

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2021 All Rights Reserved.

×